Inhaled long-acting beta agonist combined with a corticosteroid does not increase risk of death compared with corticosteroid alone

Busse WW, Bateman ED, Caplan AL, Kelly HW, O'Byrne PM, Rabe KF, et  al. Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists. N Engl J Med 2018;378:2497-505.

Source: The Journal of Pediatrics - October 22, 2018 Category: Pediatrics Authors: Carlos A. Camargo Tags: Current Best Evidence Source Type: research